Cell Therapy News Volume 23.22 | Jun 27 2022

    0
    52







    2022-06-27 | CTN 23.22


    Cell Therapy News by STEMCELL Technologies
    Vol. 23.21 – 27 June, 2022
    TOP STORY

    The Establishment of Polypeptide PSMA-Targeted Chimeric Antigen Receptor-Engineered Natural Killer Cells for Castration-Resistant Prostate Cancer and the Induction of Ferroptosis-Related Cell Death

    Scientists designed a novel CAR-natural killer cells with a clinically significant tumoricidal effect on castration-resistant prostate cancer.
    [Cancer Communications]

    Full Article
    Register now for the BCMA Targeted Therapies Summit.
    PUBLICATIONSRanked by the impact factor of the journal

    Intravenously Transplanted Mesenchymal Stromal Cells: A New Endocrine Reservoir for Cardioprotection

    Mesenchymal stem cells were isolated from human placenta tissue, and DF-MSCs or Gluc-MSCs were generated by transduced with firefly luciferase/enhanced green fluorescence protein or Gaussia luciferase lactadherin fusion protein.
    [Stem Cell Research & Therapy]

    Full Article

    Human Umbilical Cord-Derived Mesenchymal Stem Cells Not Only Ameliorate Blood Glucose but Also Protect Vascular Endothelium from Diabetic Damage through a Paracrine Mechanism Mediated by MAPK/ERK Signaling

    Scientists conducted in vivo experiment on streptozotocin-induced diabetic rat model to test body weight, fasting blood glucose, serum ICAM-1 and VCAM-1 levels, histopathology and immunohistochemical staining of aorta segments.
    [Stem Cell Research & Therapy]

    Full Article

    Kinetics of Disappearance and Appearance of Isoagglutinins A and B after ABO-Incompatible Hematopoietic Stem Cell Transplantation

    The authors investigated the time to disappearance and appearance of isoagglutinins after ABO-incompatible allogeneic hematopoietic stem cell transplantation.
    [Bone Marrow Transplantation]

    Full Article

    Human Organ Rejuvenation by VEGF-A: Lessons from the Skin

    While intradermally injected vascular endothelial growth factor (VEGF)-loaded nanoparticles sufficed to induce a molecular rejuvenation signature in aged human skin on old mice, VEGF-A treatment improved key aging parameters also in isolated, organ-cultured aged human skin.
    [Science Advances]

    Full ArticlePress Release

    Comparative Efficacy and Mechanism of Action of Cardiac Progenitor Cells after Cardiac Injury

    Transplanted neonatal mesenchymal stem cells significantly increased the number of tissue reparative macrophages and regulatory T cells and decreased monocyte-derived inflammatory macrophages and neutrophils in the host myocardium.
    [iScience]

    AbstractFull ArticleGraphical Abstract

    Development of STEAP1 Targeting Chimeric Antigen Receptor for Adoptive Cell Therapy against Cancer

    Investigators described the development of a CAR against the six-transmembrane epithelial antigen of prostate-1 (STEAP1), which is expressed in ∼90% of prostate cancers, and subgroups of other malignancies.
    [Molecular Therapy-Oncolytics]

    AbstractGraphical Abstract

    Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Diffuse Alveolar Hemorrhage Associated with Systemic Lupus Erythematosus in Mice by Promoting M2 Macrophage Polarization via the microRNA-146a-5p/NOTCH1 Axis

    Human umbilical cord mesenchymal stem cell-derived exosomes diminished NOTCH1 expression to accelerate M2 macrophage polarization via delivery of miR-146a-5p, thus alleviating systemic lupus erythematosus-associated diffuse alveolar hemorrhage in mice.
    [Immunological Investigations]

    Abstract

    The Healing of Bone Defects by Cell-Free and Stem Cell-Seeded 3D-Printed PLA Tissue-Engineered Scaffolds

    The authors showed that both cell-free and stem cell-seeded scaffolds exhibited superb healing compared with the empty defect controls, and new bone and connective tissues were formed in the healing site after 8 and 12 weeks, postoperatively.
    [Journal of Orthopaedic Surgery and Research]

    Full Article
    ON1058PSC-ISSCR-Innovation-Showcase-Webinars-Set-2_final-728-x-90-B
    REVIEWS

    Effects of Mesenchymal Stem Cell Transplantation on Spinal Cord Injury Patients

    Investigators review the beneficial effects of mesenchymal stem cell (MSC) transplantation in spinal cord injury clinical studies with a special focus on the MSC properties and limitations of MSC transplantation.
    [Cell and Tissue Research]

    Abstract
    INDUSTRY AND POLICY NEWS

    BioRestorative Therapies Announces Clinical Trial Contract with Second Site for the Company’s Phase II Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)

    BioRestorative Therapies, Inc. announced it has reached an agreement with its second clinical site for its Phase II clinical trial targeting chronic lumbar disc disease.
    [BioRestorative Therapies, Inc. (GlobeNewswire, Inc.)]

    Press Release

    TreeFrog Therapeutics Launches a $100,000 Research Grant in Regenerative Medicine

    TreeFrog Therapeutics announced the launch of The Stem Cell SpaceShot Grant, a $100,000 research funding in the field of stem cell biology and regenerative medicine.
    [TreeFrog Therapeutics]

    Press Release
    FEATURED EVENT

    49th European Muscle Conference

    September 23 – 26, 2022
    Prague, Czech Republic

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Research Associate – Alzheimer’s Disease

    The University of Arizona – Tucson, Arizona, United States

    Postdoctoral Research Scientist – Skin Cancer

    Columbia University – New York City, New York, United States

    Postdoctoral Fellow – Interorgan Crosstalk

    Washington University School of Medicine – St. Louis, Missouri, United States

    Faculty – Hematopoietic Stem Cells

    New York Blood Center – New York, New York, United States

    Postdoctoral Fellow – Tumor Microenvironment

    University of California, San Francisco – San Francisco, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cell Therapy News Twitter